Navigation Links
Bacterin Announces First Quarter 2012 Revenue of $7.8 Million, Up 29% Year-over-Year, on Gross Margins of 76%, and 34% Reduction in Operating Loss
Date:5/3/2012

3,762,211Warrant derivative liability2,126,9652,344,516Current portion of capital lease obligations84,30833,791Current portion of long-term debt2,269,4411,632,978Total current liabilities11,509,87210,940,952Long-term Liabilities:Capital lease obligation, less current portion196,83389,580Long-term debt, less current portion6,017,9796,638,270Total Liabilities17,724,68417,668,802Commitments and Contingencies Stockholders' Equity (Deficit)Preferred stock, $.000001 par value; 5,000,000 shares authorized; no shares issued andoutstanding--Common stock, $.000001 par value; 95,000,000 shares authorized; 42,524,107 shares issued and outstanding as of March 31, 2012 and 40,841,218 shares issued and outstanding as of December 31, 24340Additional paid-in capital49,984,09445,452,732Retained deficit(40,998,521)(39,951,726)Total Stockholders' Equity 8,985,6165,501,046Total Liabilities & Stockholders' Equity $

26,710,300$

23,169,848BACTERIN INTERNATIONAL HOLDINGS, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)Three Months Ended March 31,20122011RevenueTissue sales$

7,670,949$

5,868,924Royalties and other99,052131,880Total Revenue7,770,0016,000,804Cost of tissue and medical devices sales1,858,722987,356Gross Profit5,911,2795,013,448Operating ExpensesGeneral and administrative2,590,7722,391,843Sales and marketing4,146,3434,264,282Depreciation and amortization119,07452,691Non-cash consulting expense328,253240,991Total Operating Expenses7,184,4426,949,807Loss from Operations(1,273,163)(1,936,359)Other Income (Expense)Interest expense(142,852)(372,433)Change in warrant derivative liability217,5517,218,806Other income (expense)151,6696,772Total Other Income (Expense)226,3686,853,145Net Loss Before (Provision) Benefitfor Income Taxes(1,046,795)4,916,786(Provision) Benefit for Income TaxesCurrent--Deferred--Net (Loss) Income$

(1,046,795)$

4,916,786Net (loss) income per share:Basic$

(0.03)$


'/>"/>
SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Bacterin International Completes $3 Million Private Placement
2. Bacterin International Introduces OsteoSelect(R) DBM Putty
3. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
4. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
5. Bacterin International Holdings, Inc. to Present at the 6th Annual Fall Growth Stock Conference Hosted by Security Research Associates, Inc.
6. Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference
7. Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results
8. Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results
9. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
10. Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19
11. Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Texas , Nov. 21, 2014  World Hemp ... containing low THC, announces they are now offering legal, ... to Charlotte,s Web type strains grown in medical marijuana ... other neurological disorders, such as Parkinson,s, MS, and spinal ... US laws to pass, because imported CBD Oil Is ...
(Date:11/21/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... to acquire 100% of QCR & Trio Diagnostics Limited, ... organization. The transaction closed on November 17, 2014. ...
(Date:11/21/2014)... 2014 Clementia Pharmaceuticals, ... dass die Europäische Arzneimittel-Agentur (European Medicines ... Orphan-Medizinprodukt an Palovarotene vergeben hat, den ... von Fibrodysplasia ossificans progressiva (FOP). FOP ... Krankheit, die von schmerzhaften, wiederkehrenden Episoden ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... , , LINCOLNSHIRE, Ill. ... leading specialty distributor of health care products in the emergency ... has acquired CVC, Inc.  Headquartered in Arlington, Texas , ... respiratory and emergency medical services markets.   , The privately ...
... , Jan. 12 Stereotaxis (Nasdaq: ... has been approved by the U.S. Food and Drug ... the treatment of Type 1 atrial flutter.  The product ... on-going co-development agreement between Stereotaxis and Biosense Webster to ...
Cached Medicine Technology:Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products 2Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products 3Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter 2Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter 3
(Date:11/24/2014)... Recently, SweetDressy.com, a well-known dress supplier ... collection of 2014 Evening Dresses. All these fresh items ... company’s marketing manager, the special offer is valid until ... , Sweetdressy.com has been working well in the fashion ... latest designs. Their new dresses may be the best ...
(Date:11/24/2014)... 2014 SafeHandles™ announced that they will ... Ed Begley Jr, airing via Discovery Channel. Dates and ... a passive, non-invasive, replaceable, and affordable germ protective device. ... shrinkable sleeves and adhesives to promote hand hygiene in ... core of SafeHandles is the desire to make a ...
(Date:11/23/2014)... 2014 The clinical trial report, ... data on the Aspergillosis clinical trial scenario. This ... the clinical trials on Aspergillosis. It includes an ... status as per the site of trial conduction ... coverage of disease clinical trials by their phase, ...
(Date:11/23/2014)... BC (PRWEB) November 23, 2014 Pro Ace ... announced that it will now be providing an 8 year ... of hot water tank installations went up due to the ... to assure its customers of the premium service that the ... offering 8 year warranty on John Wood and Bradford hot ...
(Date:11/23/2014)... This evaluation provides a basic conclusion ... and manufacturing technological innovation. Then, the evaluation investigates ... in information. In this part, the evaluation provides ... and 2009-2014 market shares for each company. Through ... and Chinese suppliers finish market of Femoral Occurs ...
Breaking Medicine News(10 mins):Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4
... transplantation of stem cells from a healthy donor (allogeneic) ... aggressive form of chronic lymphocytic leukemia (CLL), irrespective of ... disease. The German CLL Study Group proved this in ... Dr. Peter Dreger, senior consultant and head of the ...
... evaluating the effectiveness of a broad selection of popular ... has found no evidence that any of them facilitate ... presented today (Monday) at the International Congress on Obesity ... effective than the fake supplements they were compared with. ...
... cancer patients who reported poor sleep quality one year after ... dry mouth related to radiation treatments, according to a recent ... Because these side effects can be controlled or modified, the ... cancer patients may be warranted to improve sleep hygiene and ...
... immediate antiretroviral treatment (ART) for infected individuals could have a ... a new study finds that it would not halt the ... a paper that will appear in the August 15 issue ... online, researchers find that the so-called "test-and-treat" strategy could reduce ...
... ... company (Pink Sheets: GDAR), has terminated it,s previously announced strategic alliance with JK Development ... ... Inc., a publicly traded company (Pink Sheets: GDAR), has terminated it,s previously announced strategic ...
... The Kristen Renee ... local campaign set out to fight for the city residents continues to fight for answers ... and BBQ., , ... 9, 2010 -- The Kristen Renee Foundation has launched a campaign to research and investigate ...
Cached Medicine News:Health News:Stem cell transplantation of therapy-resistant chronic leukemia successful 2Health News:New research finds no evidence that popular slimming supplements facilitate weight loss 2Health News:New research finds no evidence that popular slimming supplements facilitate weight loss 3Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 2Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 3Health News:Universal HIV testing and immediate treatment could reduce but not eliminate HIV/AIDS epidemic 2Health News:Golden Age Resources, Inc Terminates Alliance with JK Development of Palm Beach County LLC. 2Health News:The Kristen Renee Foundation Continues to Fight for Frederick, MD for Answers from the EPA and Fort Deterick 2Health News:The Kristen Renee Foundation Continues to Fight for Frederick, MD for Answers from the EPA and Fort Deterick 3Health News:The Kristen Renee Foundation Continues to Fight for Frederick, MD for Answers from the EPA and Fort Deterick 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: